vimarsana.com

Page 13 - ப்ரிஸ்க்ரிப்ஶந் மருந்து பயனர் கட்டணம் நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Reassessing Risk Management with Corporate Event Data

Traders Magazine Understanding and Identifying Risk A well-known pillar of risk management is that one must first understand risk in order to manage it. “Understanding risk requires the ability to quantify a given risk so that mitigating controls can be put in place to reduce the risk to an acceptable level, a level that is in line with the organization’s risk appetite framework. Without the ability to effectively quantify risk, no risk program can be successful.” 2 Once we define risk, we can calculate and manage it. However, assessing risk is not a simple task. Risk is an inherent part of investing that even the most successful investors can’t avoid. To help minimize the impact, firms hire risk managers to analyze and attribute critical sources of risk in the market. The risk manager rifles through data for any insights that may improve investment behavior or portfolio construction. However, managing risk is not about eliminating it. Instead, investors or risk manag

LIEBERMAN: Will new Alzheimer s drug really cure disease? |

A few weeks ago a new drug to treat Alzheimer’s disease hit the market. The FDA announced it had approved aducanumab marketed under the brand name Aduhelm by the biotech company Biogen. Predictably, the Alzheimer’s Association, a patient advocacy group, hailed the news as a “victory for people living with Alzheimer’s and their families” and one that “ushers in a new era in Alzheimer’s treatment and research.” Such glowing statements from patient advocacy groups are common when a new pharmaceutical hits the market. So it’s no wonder the Alzheimer’s Association announced that it “enthusiastically welcomes” the drug’s “historic FDA approval.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.